Diagnosis and treatment of : Testicular cancerBOYER, Michael J.Current therapeutics. 2001, Vol 42, Num 5, pp 25-29, issn 0311-905XArticle

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyVAN CUTSEM, Eric; TWELVES, Chris; MCKENDRICK, Joe et al.Journal of clinical oncology. 2001, Vol 19, Num 21, pp 4097-4106, issn 0732-183XArticle

How to identify and remove the barriers for a successful lean implementationBOYER, Michael; SOVILLA, Lisa.Journal of ship production. 2003, Vol 19, Num 2, pp 116-120, issn 8756-1417, 5 p.Conference Paper

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural MesotheliomaNOWAK, Anna K; BROWN, Chris; PAVLAKIS, Nick et al.Lung cancer. 2013, Vol 81, Num 3, pp 422-427, issn 0169-5002, 6 p.Article

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research GroupYEO, Winnie; CHUNG, Hyun C; HUI, Edwin P et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3361-3367, issn 0732-183X, 7 p.Article

Predicting the toxicity of weekly docetaxel in advanced cancerCHARLES, Kellie A; RIVORY, Laurent P; STOCKLER, Martin R et al.Clinical pharmacokinetics. 2006, Vol 45, Num 6, pp 611-622, issn 0312-5963, 12 p.Article

Cancer consultation preparation package: Changing patients but not physicians is not enoughBUTOW, Phyllis; DEVINE, Rhonda; BOYER, Michael et al.Journal of clinical oncology. 2004, Vol 22, Num 21, pp 4401-4409, issn 0732-183X, 9 p.Article

Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factorsYAN, Tristan D; BOYER, Michael; MO MO TIN et al.Journal of thoracic and cardiovascular surgery (Print). 2009, Vol 138, Num 3, pp 619-624, issn 0022-5223, 6 p.Article

Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural MesotheliomaYAN, Tristan D; BOYER, Michael; MO MO TIN et al.The Annals of thoracic surgery. 2009, Vol 87, Num 5, pp 1552-1557, issn 0003-4975, 6 p.Article

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung CancerMOK, Tony S. K; WU, Yi-Long; CHUA-TAN, Marina et al.Journal of clinical oncology. 2009, Vol 27, Num 30, pp 5080-5087, issn 0732-183X, 8 p.Article

Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinomaOATES, Justine E; CLARK, Jonathan R; READ, Jane et al.Archives of otolaryngology, head & neck surgery. 2007, Vol 133, Num 6, pp 533-540, issn 0886-4470, 8 p.Article

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaVOGELZANG, Nicholas J; RUSTHOVEN, James J; NIYIKIZA, Clet et al.Journal of clinical oncology. 2003, Vol 21, Num 14, pp 2636-2644, issn 0732-183X, 9 p.Article

Optimizing the erythromycin breath test for use in cancer patientsRIVORY, Laurent P; SLAVIERO, Kellie; SEALE, J. Paul et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3480-3485, issn 1078-0432Article

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR MutationsSEQUIST, Lecia V; YANG, James Chih-Hsin; SU, Wu-Chou et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3327-3334, issn 0732-183X, 8 p.Article

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan―Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; BLACKHALL, Fiona; LETRENT, Stephen P et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3337-3344, issn 0732-183X, 8 p.Article

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As FirstLine Treatment for Advanced Non―Small-Cell Lung CancerHIRSH, Vera; PAZ-ARES, Luis; BAJETTA, Emilio et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2667-2674, issn 0732-183X, 8 p.Article

A performance study of general-purpose applications on graphics processors using CUDASHUAI CHE; BOYER, Michael; JIAYUAN MENG et al.Journal of parallel and distributed computing (Print). 2008, Vol 68, Num 10, pp 1370-1380, issn 0743-7315, 11 p.Article

Consensus report : Pretreatment minimal staging and treatment of potentially resectable malignant pleural mesotheliomaVAN MEERBEECK, Jan P; BOYER, Michael.Lung cancer. 2005, Vol 49, pp S123-S127, issn 0169-5002, SUP1Conference Paper

Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cellsMEI ZHANG; BOYER, Michael; RIVORY, Laurent et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 2, pp 353-360, issn 0360-3016, 8 p.Conference Paper

Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancerHORVATH, Lisa; BOYER, Michael; CLARKE, Stephen et al.Lung cancer. 2001, Vol 32, Num 2, pp 173-178, issn 0169-5002Article

Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatographyRIVORY, Laurent P; CLARKE, Stephen J; BOYER, Michael et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 765, Num 2, pp 135-140, issn 1387-2273Article

The rapid improvement workshop as a tool for changeBOYER, Michael D.Journal of ship production. 2002, Vol 18, Num 3, pp 152-158, issn 8756-1417Article

Current management of lung cancerBOYER, Michael J; CLARKE, Stephen J.Current therapeutics. 2002, Vol 43, Num 12, pp 49-54, issn 0311-905X, 6 p.Article

Role of Hog1, Tps1 and Sod1 in boric acid tolerance of Saccharomyces cerevisiaeSCHMIDT, Martin; AKASAKA, Kento; MESSERLY, Jeffrey T et al.Microbiology (Reading). 2012, Vol 158, pp 2667-2678, issn 1350-0872, 12 p., 10Article

Duration of Chemotherapy for Advanced Non―Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized TrialsYU YANG SOON; STOCKLER, Martin R; ASKIE, Lisa M et al.Journal of clinical oncology. 2009, Vol 27, Num 20, pp 3277-3283, issn 0732-183X, 7 p.Article